Integrating drug permeability with dissolution profile to develop IVIVC
- PMID: 22581486
- DOI: 10.1002/bdd.1792
Integrating drug permeability with dissolution profile to develop IVIVC
Abstract
In this review article, three different approaches to predict in vivo oral absorption based on the in vitro data of drug permeability, solubility and dissolution were introduced. At the drug discovery stage, the absorption potential of each candidate is most important to select better compounds for further development. The concept of maximum absorbable dose is applied widely, not only to evaluate the absorption potential but also to elucidate the rate-limiting process of oral absorption that helps us to understand the cause of poor absorption. To integrate the permeability of the drug with its dissolution profile, two different approaches, in vitro dissolution/permeation system (D/P system) and in silico model and simulation method, are proposed. In the D/P system, by mimicking the in vivo process of drug absorption, the permeated amount of drugs, that is the total output of dissolution and permeation processes, are correlated with the fraction absorbed in human (F(a)). This system is powerful for evaluating the improved absorption by various formulations and the effect of food intake. On the other hand, in the model and simulation approach, an intrinsic dissolution parameter of drug particle, z, was extracted from the small scale in vitro test and the process of intestinal absorption was re-constructed in silico by incorporating the physiological parameters in human. The effective use of these approaches for the development of oral drug products is discussed through various case studies.
Copyright © 2012 John Wiley & Sons, Ltd.
Similar articles
-
In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.Eur J Pharm Sci. 2013 Jul 16;49(4):679-98. doi: 10.1016/j.ejps.2013.05.019. Epub 2013 May 29. Eur J Pharm Sci. 2013. PMID: 23727464
-
Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.Mol Pharm. 2016 May 2;13(5):1564-74. doi: 10.1021/acs.molpharmaceut.6b00044. Epub 2016 Apr 13. Mol Pharm. 2016. PMID: 27031624
-
Prediction of human pharmacokinetics--gastrointestinal absorption.J Pharm Pharmacol. 2007 Jul;59(7):905-16. doi: 10.1211/jpp.59.7.0001. J Pharm Pharmacol. 2007. PMID: 17637184 Review.
-
Regional intestinal drug permeation: biopharmaceutics and drug development.Eur J Pharm Sci. 2014 Jun 16;57:333-41. doi: 10.1016/j.ejps.2013.08.025. Epub 2013 Aug 27. Eur J Pharm Sci. 2014. PMID: 23988845 Review.
-
Predicting the oral absorption of a poorly soluble, poorly permeable weak base using biorelevant dissolution and transfer model tests coupled with a physiologically based pharmacokinetic model.Eur J Pharm Biopharm. 2012 Sep;82(1):127-38. doi: 10.1016/j.ejpb.2012.05.008. Epub 2012 May 28. Eur J Pharm Biopharm. 2012. PMID: 22652546 Clinical Trial.
Cited by
-
Deconvolution and IVIVC: Exploring the Role of Rate-Limiting Conditions.AAPS J. 2016 Mar;18(2):321-32. doi: 10.1208/s12248-015-9849-y. Epub 2015 Dec 14. AAPS J. 2016. PMID: 26667356 Free PMC article.
-
Spray Congealing: An Emerging Technology to Prepare Solid Dispersions with Enhanced Oral Bioavailability of Poorly Water Soluble Drugs.Molecules. 2019 Sep 25;24(19):3471. doi: 10.3390/molecules24193471. Molecules. 2019. PMID: 31557815 Free PMC article. Review.
-
"Development of Fixed Dose Combination Products" Workshop Report: Considerations of Gastrointestinal Physiology and Overall Development Strategy.AAPS J. 2019 Jun 6;21(4):75. doi: 10.1208/s12248-019-0346-6. AAPS J. 2019. PMID: 31172358
-
Elucidating the role of dose in the biopharmaceutics classification of drugs: the concepts of critical dose, effective in vivo solubility, and dose-dependent BCS.Pharm Res. 2012 Nov;29(11):3188-98. doi: 10.1007/s11095-012-0815-4. Epub 2012 Jul 4. Pharm Res. 2012. PMID: 22760660
-
The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC.Eur J Pharm Sci. 2014 Jun 16;57:152-63. doi: 10.1016/j.ejps.2014.01.009. Epub 2014 Jan 28. Eur J Pharm Sci. 2014. PMID: 24486482 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical